Eflornithine
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
- Eflornithine (IV): no longer commercially available in the U.S.
- Treatment of unwanted facial hair in women (topical cream)
NON-FDA APPROVED USES
- African trypanosomiasis (sleeping sickness):Second-stage T. b. gambiense
- Eflornithine is not effective against T. b. rhodesiense(East African form of the diseases)
- Drug can be obtained from CDC by contacting the Division of Parasitic Diseases and Malaria (telephone, 404-718-4745; email, parasites@cdc.gov).
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
- Eflornithine (IV): no longer commercially available in the U.S.
- Treatment of unwanted facial hair in women (topical cream)
NON-FDA APPROVED USES
- African trypanosomiasis (sleeping sickness):Second-stage T. b. gambiense
- Eflornithine is not effective against T. b. rhodesiense(East African form of the diseases)
- Drug can be obtained from CDC by contacting the Division of Parasitic Diseases and Malaria (telephone, 404-718-4745; email, parasites@cdc.gov).
There's more to see -- the rest of this topic is available only to subscribers.